h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Naming Tool
Publishing your line
Structures & Partners
Registration Summary
Certification
API
Export Data
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
INMi001-A
Registration Summary
:
A
P
E
C
USH2A-RP-iPSC
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg Name
A standardised name that was automatically generated based on the cell line information. see
Naming Tool
INMi001-A
Alternative name(s)
USH2A-RP-iPSC
Cell line type
Human induced pluripotent stem cell (hiPSC)
Last update
14th September 2018
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Institute for Neurosciences of Montpellier (INM)
External Databases
Cellosaurus
CVCL_UJ75
Wikidata
Q94317981
General Information
Publications
Sanjurjo-Soriano C et al. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa. Stem cell research. 2018 Dec;33:228-232.
Erkilic N et al. A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia. Cells. 2019 Sep 11;8(9).
Sanjurjo-Soriano C et al. Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles. Molecular therapy. Methods & clinical development. 2020 Jun 12;17:156-173.
Liu X et al. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells. Genes. 2021 May 25;12(6).
Hosseini Shabanan S et al. Stem cell transplantation as a progressing treatment for retinitis pigmentosa. Cell and tissue research. 2022 Feb;387(2):177-205.
Zaw K et al. Pathogenesis and Treatment of Usher Syndrome Type IIA. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2022 Jul-Aug 01;11(4):369-379.
Sanjurjo-Soriano C et al. Retinoic acid delays initial photoreceptor differentiation and results in a highly structured mature retinal organoid. Stem cell research & therapy. 2022 Sep 16;13(1):478.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.